The Role of Technetium-99m Sulfur Colloid in Diagnostic Imaging

Technetium-99m (Tc-99m) sulfur colloid is an essential radiopharmaceutical used widely in the field of diagnostic imaging, particularly in nuclear medicine. This radioactive compound has played a pivotal role in evaluating and diagnosing various medical conditions, especially those related to the liver, spleen, and bone marrow, and investigating certain gastrointestinal disorders. Tc-99m sulfur colloid imaging leverages the unique properties of technetium-99m, which, when attached to sulfur colloid particles, allows for the visual inspection of organ function and structure through gamma camera imaging.

Radiopharmaceutical Properties and Production

Technetium-99m, the metastable isotope of technetium, is preferred in medical imaging due to its ideal physical half-life of approximately 6 hours, which is long enough to perform diagnostic procedures but short enough to minimise radiation exposure to the patient. Additionally, the gamma radiation it emits is at an energy level of 140 keV, which is readily detected by gamma cameras while being low enough to keep the patient dose as low as reasonably achievable.

The production of Tc-99m is typically achieved using a molybdenum-99/technetium-99m (Mo-99/Tc-99m) generator; Mo-99 decays to Tc-99m, which can be extracted through a saline elution process. The resulting Tc-99m is then compounded with sodium pertechnetate and mixed with a sulfur colloid to create the Tc-99m sulfur colloid used in diagnostics.

Mechanism of Localisation

Once injected into the body, the Tc-99m sulfur colloid particles are phagocytosed by the reticuloendothelial system (RES), which predominantly consists of macrophages located in the liver, spleen, and bone marrow. The size of the colloid particles dictates their biodistribution, with larger particles tending to localise more in the liver and smaller ones in the bone marrow and spleen.

Clinical Applications

The ability to visualise organ function and vascular integrity in real-time presents a significant advantage in diagnostic imaging. Tc-99m sulfur colloid is used for several clinical applications:

  • Liver and Spleen Scintigraphy: This is the most common use of Tc-99m sulfur colloid, providing essential diagnostic information about the size, shape, and function of the liver and spleen. It is particularly useful in detecting focal lesions such as cysts, abscesses, and tumours. In cases of trauma, scintigraphy can assess the integrity of these organs.
  • Gastrointestinal Bleeding: Tc-99m sulfur colloid is useful for locating sites of active gastrointestinal bleeding. After intravenous administration, if there is an area of bleeding within the gastrointestinal tract, the radiotracer can escape from the vasculature and collect at the bleeding site, allowing for localisation by imaging.
  • Gastric Emptying Studies: It helps in assessing gastric emptying by tagging a meal with Tc-99m sulfur colloid. Gamma camera imaging tracks the movement of the radioactive meal through the stomach, helping in the diagnosis of conditions like gastroparesis.
  • Bone Marrow Scintigraphy: This application is vital in evaluating the distribution and function of the bone marrow. It can aid in the diagnosis of disorders such as aplastic anaemia myelofibrosis, and the evaluation of bone marrow after chemotherapy or radiation therapy.
  • Sentinel Node Biopsy: Tc-99m sulfur colloid is also used in sentinel lymph node mapping in cancer patients. The colloid is injected near the tumour site and migrates to the first draining lymph node, the sentinel node. Gamma imaging then helps locate this node for biopsy to determine the spread of cancer, particularly breast cancer and melanoma.

Advantages and Safety

One of the main advantages of using Tc-99m sulfur colloid in diagnostic imaging is its safety profile. The isotope’s short half-life and relatively low-energy gamma emission minimise radiation exposure. The use of Tc-99m also allows for the use of smaller amounts of radiopharmaceutical to obtain the necessary diagnostic information, further reducing the risk to patients.

Additionally, Tc-99m sulfur colloid scans are non-invasive and can provide functional information that cannot be obtained through other imaging modalities such as CT or MRI. This functional aspect is critical in many diagnoses, as it can sometimes reveal abnormalities that structural imaging cannot detect.

Technical Considerations

The preparation and use of Tc-99m sulfur colloid require adherence to strict protocols to ensure the safety and efficacy of the diagnostic procedure. The size of the sulfur colloid particles must be controlled during preparation, as this influences the biodistribution of the tracer. Furthermore, the technicians and radiologists involved in the imaging process must be thoroughly trained in handling radioactive materials and interpreting the images produced.

The interpretation of images obtained using Tc-99m sulfur colloid can be complex and requires a detailed understanding of the normal and pathological distribution of the tracer. Variations in uptake may indicate different pathologies, but these must be carefully differentiated from normal anatomical variations or technical artefacts. For instance, in liver imaging, areas of decreased uptake may indicate a lesion or tumour but could also be due to cysts, focal nodular hyperplasia, or artefacts from adjacent organs or bowel gas. Therefore, the skill and experience of the nuclear medicine physician are critical in providing an accurate diagnosis.

Integration with Other Imaging Modalities

The information obtained from Tc-99m sulfur colloid scans can be complemented by other imaging modalities. For example, abnormal findings on a colloid scan can prompt further investigation with ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) to better characterise a lesion or to guide biopsy. Moreover, advances in hybrid imaging techniques, such as SPECT/CT (Single Photon Emission Computed Tomography/Computed Tomography), allow for the anatomical localisation of functional abnormalities detected by Tc-99m sulfur colloid, enhancing diagnostic accuracy.


While Tc-99m sulfur colloid is an invaluable diagnostic tool, it is not without limitations. The resolution of images is generally lower than that of CT or MRI; in some cases, additional imaging studies may be necessary to confirm findings. There may also be contraindications or limitations in patients with allergies to the components of the colloid or in those with severe liver or spleen dysfunction, which could affect the distribution and uptake of the tracer.

Furthermore, the reliance on the Mo-99/Tc-99m generator system means that any disruption in the supply of Mo-99 can impact the availability of Tc-99m. This has been a concern in the past due to the limited number of nuclear reactors capable of producing Mo-99.

Future Directions

Research into new imaging agents and techniques is ongoing, and there may be developments that could supplement or replace Tc-99m sulfur colloid in certain applications. For instance, advancements in PET (Positron Emission Tomography) tracers and MRI contrast agents may offer higher-resolution images or provide different types of functional information. Nevertheless, the utility, availability, and cost-effectiveness of Tc-99m sulfur colloid ensure that it remains a mainstay in diagnostic imaging for the foreseeable future.


Tc-99m sulfur colloid is a fundamental component in the arsenal of diagnostic imaging tools, with wide-ranging applications from liver and spleen imaging to the investigation of bone marrow pathologies and sentinel lymph node identification. Its role in the quick and accurate diagnosis of numerous medical conditions exemplifies the importance of nuclear medicine in modern healthcare. As technology and medical knowledge advance, the use of Tc-99m sulfur colloid will likely evolve, but its impact on patient care will remain significant, continuing to aid clinicians in the crucial task of diagnosing and managing patient health.

You Are Here: Home » technetium-99m sulfur colloid
Tags: Radiopharmaceuticals, Technetium-99m
Open Medscience